Literature DB >> 14695232

The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process.

Bradley T Messmer1, Emilia Albesiano, Davorka Messmer, Nicholas Chiorazzi.   

Abstract

The overexpanded clone in most B-cell-type chronic lymphocytic leukemia (BCLL) patients expresses an immunoglobulin (Ig) heavy chain variable (V(H)) region gene with some level of mutation. While it is presumed that these mutations were introduced in the progenitor cell of the leukemic clone by the canonical somatic hypermutation (SHM) process, direct evidence of such is lacking. Nucleotide sequences of the Ig V(H) genes from 172 B-CLL patients were analyzed. Previously described V(H) gene usage biases were noted. As with canonical SHM, mutations found in B-CLL were more frequent in RGYW hot spots (mutations in an RGYW motif = 44.1%; germ line frequency of RGYW motifs = 25.6%) and favored transitions over transversions (transition-transversion ratio = 1.29). Significantly, transition preference was also noted when only mutations in the wobble position of degenerate codons were considered. Wobble positions are inherently unselected since regardless of change an identical amino acid is encoded; therefore, they represent a window into the nucleotide bias of the mutational mechanism. B-CLL V(H) mutations concentrated in complementarity-determining region 1 (CDR1) and CDR2, which exhibited higher replacement-to-silent ratios (CDR R/S, 4.60; framework region [FR] R/S, 1.72). These results are consistent with the notion that V(H) mutations in B-CLL cells result from canonical SHM and select for altered, structurally sound antigen receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695232     DOI: 10.1182/blood-2003-10-3407

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Targets of somatic hypermutation within immunoglobulin light chain genes in zebrafish.

Authors:  Alexis E Marianes; Anastasia M Zimmerman
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

Review 2.  Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.

Authors:  Gerard Tobin; Richard Rosenquist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

3.  Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.

Authors:  Fabio Ghiotto; Franco Fais; Emilia Albesiano; Cristina Sison; Angelo Valetto; Gianluca Gaidano; Janine Reinhardt; Jonathan E Kolitz; Kanti Rai; Steven L Allen; Manlio Ferrarini; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

4.  B-cell clones as early markers for chronic lymphocytic leukemia.

Authors:  Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard B Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

5.  CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Authors:  Lucile Baseggio; Alexandra Traverse-Glehen; Florence Petinataud; Evelyne Callet-Bauchu; Françoise Berger; Martine Ffrench; Chantal Marie Couris; Catherine Thieblemont; Dominique Morel; Bertrand Coiffier; Gilles Salles; Pascale Felman
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

6.  Evidence of canonical somatic hypermutation in hairy cell leukemia.

Authors:  Evgeny Arons; Laura Roth; Jeffrey Sapolsky; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2011-03-02       Impact factor: 22.113

7.  Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells.

Authors:  Jie Zheng; Jing Huang; Yuntao Mao; Shiqing Liu; Xin Sun; Xiaohui Zhu; Teng Ma; Li Zhang; Jiafu Ji; Youhui Zhang; C Cameron Yin; Xiaoyan Qiu
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 8.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

9.  IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.

Authors:  Piers E M Patten; Charles C Chu; Emilia Albesiano; Rajendra N Damle; Xiao-Jie Yan; Dorothy Kim; Lu Zhang; Amanda R Magli; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Sergio Roa; Patricia K Mongini; Thomas MacCarthy; Matthew D Scharff; Nicholas Chiorazzi
Journal:  Blood       Date:  2012-10-15       Impact factor: 22.113

Review 10.  Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.

Authors:  Michele Dal-Bo; Francesco Bertoni; Francesco Forconi; Antonella Zucchetto; Riccardo Bomben; Roberto Marasca; Silvia Deaglio; Luca Laurenti; Dimitar G Efremov; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  J Transl Med       Date:  2009-08-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.